Tag: nasdaq:rare

March 9, 2020

8 Small Biotech ETFs

Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
February 27, 2020

Ultragenyx, Kyowa Kirin Announce FDA Acceptance for Supplemental Biologics License

Ultragenyx and Kyowa Kirin announced that the FDA has accepted for review the supplemental Biologics License Application for Crysvita for...
August 14, 2019

Ultragenyx Partners with GeneTx to Advance Treatment for Angelman Syndrome

Ultragenyx Pharmaceutical (NASDAQ:RARE) has announced it has partnered with GeneTx Biotherapeutics to develop GeneTx’s GTX-102 drug to treat Angelman syndrome....
January 17, 2019

How Will the FDA Shutdown Affect the Biotech Industry?

No information has been released on how the FDA will manage the possible influx of drug applications once the shutdown...
December 19, 2018

Biotech Outlook 2019: Will the Pressure Continue?

With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in...
December 6, 2018

Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita

Ultragenyx Pharmaceutical (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases,...
October 18, 2018

Ultragenyx Announces Approval of Mepsevii in Brazil for the Treatment of Mucopolysaccharidosis VII

Ultragenyx Pharmaceutical (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases,...